NASDAQ:PMTI

Palomar Medical Technologies (PMTI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
128,366 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PMTI stock logo

About Palomar Medical Technologies Stock (NASDAQ:PMTI)

Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.

PMTI Stock News Headlines

Dynamic Medical Technologies Inc 4138
The 2024 Gold Rush: Unleashing Market Potential
Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.
NeuroOne Medical Technologies Corporation (NMTC)
Scripps Memorial Hospital-Encinitas
Palomar Medical Center Poway
Palomar Medical Center Escondido
The 2024 Gold Rush: Unleashing Market Potential
Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.
NMTC NeuroOne Medical Technologies Corporation
4 Analysts Have This to Say About Palomar Hldgs
Where Palomar Hldgs Stands With Analysts
See More Headlines
Receive PMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Palomar Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:PMTI
CUSIP
69752930
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Joseph P. Caruso (Age 54)
    Chairman of the Board, President, Chief Executive Officer
  • Paul S. Weiner (Age 53)
    Chief Financial Officer, Treasurer
  • Louis P. Valente (Age 81)
    Director
  • Jeanne Cohane (Age 65)
    Independent Director
  • Damian N. Dell'Anno
    Independent Director
  • Nicholas P. Economou Ph.D. (Age 63)
    Independent Director
  • James G. Martin Ph.D. (Age 78)
    Independent Director

PMTI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Palomar Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Palomar Medical Technologies investors own include Overstock.com (OSTK), Aruba Networks (ARUN), Ariad Pharmaceuticals (ARIA), Argos Therapeutics (ARGSQ), Arcturus Therapeutics (ARCT), Aptinyx (APTX), Aptiv (APTV), Digital Turbine (APPS), Senmiao Technology (AIHS) and AGNC Investment (AGNC).

This page (NASDAQ:PMTI) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners